Endo Announces Actions to Drive Greater Efficiency and Business Alignment
Endo International
Posted on: 29 Jan 17
DUBLIN, Jan. 26, 2017 /PRNewswire/ — Endo International plc (NASDAQ / TSX: ENDP) announced today that as part of its comprehensive organizational review, it has initiated a restructuring program. These restructuring actions primarily relate to the Company’s Corporate functions and Branded pharmaceutical R&D functions in Malvern, PA and Chestnut Ridge, NY. The restructuring program will better align these parts of our organization in size and scope with the Company’s recently restructured Generics and U.S Branded Pharmaceutical business units. In addition to realizing greater efficiencies, these actions are expected to pro…
Read the full article at: http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=202986